VERACYTE INC (VCYT) Fundamental Analysis & Valuation

NASDAQ:VCYT • US92337F1075

32.46 USD
-0.32 (-0.98%)
At close: Mar 11, 2026
32.46 USD
0 (0%)
After Hours: 3/11/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This VCYT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

VCYT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 519 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making VCYT a very profitable company, without any liquidiy or solvency issues. VCYT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, VCYT could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. VCYT Profitability Analysis

1.1 Basic Checks

  • VCYT had positive earnings in the past year.
  • In the past year VCYT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: VCYT reported negative net income in multiple years.
  • Of the past 5 years VCYT 4 years had a positive operating cash flow.
VCYT Yearly Net Income VS EBIT VS OCF VS FCFVCYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • With an excellent Return On Assets value of 4.72%, VCYT belongs to the best of the industry, outperforming 91.14% of the companies in the same industry.
  • VCYT's Return On Equity of 5.07% is amongst the best of the industry. VCYT outperforms 90.56% of its industry peers.
  • With an excellent Return On Invested Capital value of 4.59%, VCYT belongs to the best of the industry, outperforming 90.94% of the companies in the same industry.
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROIC 4.59%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
VCYT Yearly ROA, ROE, ROICVCYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • VCYT has a better Profit Margin (12.83%) than 91.91% of its industry peers.
  • The Operating Margin of VCYT (15.14%) is better than 92.29% of its industry peers.
  • VCYT has a Gross Margin of 70.10%. This is amongst the best in the industry. VCYT outperforms 80.92% of its industry peers.
  • In the last couple of years the Gross Margin of VCYT has grown nicely.
Industry RankSector Rank
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
VCYT Yearly Profit, Operating, Gross MarginsVCYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. VCYT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VCYT is destroying value.
  • The number of shares outstanding for VCYT has been increased compared to 1 year ago.
  • VCYT has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VCYT Yearly Shares OutstandingVCYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VCYT Yearly Total Debt VS Total AssetsVCYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • An Altman-Z score of 16.75 indicates that VCYT is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 16.75, VCYT belongs to the best of the industry, outperforming 86.71% of the companies in the same industry.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.75
ROIC/WACC0.52
WACC8.79%
VCYT Yearly LT Debt VS Equity VS FCFVCYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 8.15 indicates that VCYT has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 8.15, VCYT is doing good in the industry, outperforming 73.99% of the companies in the same industry.
  • A Quick Ratio of 7.81 indicates that VCYT has no problem at all paying its short term obligations.
  • VCYT has a better Quick ratio (7.81) than 72.64% of its industry peers.
Industry RankSector Rank
Current Ratio 8.15
Quick Ratio 7.81
VCYT Yearly Current Assets VS Current LiabilitesVCYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. VCYT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 176.67% over the past year.
  • The Revenue has grown by 16.01% in the past year. This is quite good.
  • VCYT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.50% yearly.
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.22% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 10.74% on average over the next years. This is quite good.
EPS Next Y39.38%
EPS Next 2Y26.95%
EPS Next 3Y26.37%
EPS Next 5Y21.22%
Revenue Next Year12.64%
Revenue Next 2Y12.58%
Revenue Next 3Y12.06%
Revenue Next 5Y10.74%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VCYT Yearly Revenue VS EstimatesVCYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
VCYT Yearly EPS VS EstimatesVCYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. VCYT Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 39.11, VCYT can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, VCYT is valued cheaper than 90.75% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of VCYT to the average of the S&P500 Index (26.15), we can say VCYT is valued slightly more expensively.
  • VCYT is valuated quite expensively with a Price/Forward Earnings ratio of 28.06.
  • Based on the Price/Forward Earnings ratio, VCYT is valued cheaper than 92.87% of the companies in the same industry.
  • VCYT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 39.11
Fwd PE 28.06
VCYT Price Earnings VS Forward Price EarningsVCYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 93.26% of the companies in the same industry are more expensive than VCYT, based on the Enterprise Value to EBITDA ratio.
  • VCYT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VCYT is cheaper than 95.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.37
EV/EBITDA 21.48
VCYT Per share dataVCYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • VCYT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • VCYT has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as VCYT's earnings are expected to grow with 26.37% in the coming years.
PEG (NY)0.99
PEG (5Y)N/A
EPS Next 2Y26.95%
EPS Next 3Y26.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VCYT Dividend Analysis

5.1 Amount

  • No dividends for VCYT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VCYT Fundamentals: All Metrics, Ratios and Statistics

VERACYTE INC

NASDAQ:VCYT (3/11/2026, 8:00:02 PM)

After market: 32.46 0 (0%)

32.46

-0.32 (-0.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners110.45%
Inst Owner Change-4.94%
Ins Owners0.42%
Ins Owner Change-0.09%
Market Cap2.58B
Revenue(TTM)517.14M
Net Income(TTM)66.35M
Analysts82.11
Price Target50.17 (54.56%)
Short Float %7.67%
Short Ratio7.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.79%
Min EPS beat(2)79.03%
Max EPS beat(2)132.56%
EPS beat(4)3
Avg EPS beat(4)43.36%
Min EPS beat(4)-110.32%
Max EPS beat(4)132.56%
EPS beat(8)6
Avg EPS beat(8)164.25%
EPS beat(12)8
Avg EPS beat(12)72.71%
EPS beat(16)12
Avg EPS beat(16)65.75%
Revenue beat(2)2
Avg Revenue beat(2)3.25%
Min Revenue beat(2)3.19%
Max Revenue beat(2)3.31%
Revenue beat(4)4
Avg Revenue beat(4)3.32%
Min Revenue beat(4)1.01%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)3.84%
Revenue beat(12)11
Avg Revenue beat(12)4.44%
Revenue beat(16)15
Avg Revenue beat(16)5.09%
PT rev (1m)0.93%
PT rev (3m)1.69%
EPS NQ rev (1m)5.09%
EPS NQ rev (3m)-9.81%
EPS NY rev (1m)2.37%
EPS NY rev (3m)10.57%
Revenue NQ rev (1m)0.6%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)1.2%
Revenue NY rev (3m)2.33%
Valuation
Industry RankSector Rank
PE 39.11
Fwd PE 28.06
P/S 4.99
P/FCF 20.37
P/OCF 18.92
P/B 1.97
P/tB 5.69
EV/EBITDA 21.48
EPS(TTM)0.83
EY2.56%
EPS(NY)1.16
Fwd EY3.56%
FCF(TTM)1.59
FCFY4.91%
OCF(TTM)1.72
OCFY5.28%
SpS6.51
BVpS16.48
TBVpS5.7
PEG (NY)0.99
PEG (5Y)N/A
Graham Number17.54
Profitability
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROCE 5.82%
ROIC 4.59%
ROICexc 6.63%
ROICexgc 80.43%
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
FCFM 24.49%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.19%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 136.72%
Profit Quality 190.84%
Current Ratio 8.15
Quick Ratio 7.81
Altman-Z 16.75
F-Score8
WACC8.79%
ROIC/WACC0.52
Cap/Depr(3y)43.31%
Cap/Depr(5y)38.08%
Cap/Sales(3y)2.39%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
EPS Next Y39.38%
EPS Next 2Y26.95%
EPS Next 3Y26.37%
EPS Next 5Y21.22%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%
Revenue Next Year12.64%
Revenue Next 2Y12.58%
Revenue Next 3Y12.06%
Revenue Next 5Y10.74%
EBIT growth 1Y301.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year205.84%
EBIT Next 3Y58.94%
EBIT Next 5Y37.52%
FCF growth 1Y98.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.51%
OCF growth 3Y162.45%
OCF growth 5YN/A

VERACYTE INC / VCYT FAQ

What is the fundamental rating for VCYT stock?

ChartMill assigns a fundamental rating of 7 / 10 to VCYT.


What is the valuation status of VERACYTE INC (VCYT) stock?

ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.


How profitable is VERACYTE INC (VCYT) stock?

VERACYTE INC (VCYT) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for VCYT stock?

The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 39.11 and the Price/Book (PB) ratio is 1.97.


What is the financial health of VERACYTE INC (VCYT) stock?

The financial health rating of VERACYTE INC (VCYT) is 8 / 10.